Webinar

Innovation After EASD: Market Trends and Clinical Takeaways: BI Replay

By submitting this information, I agree to the privacy policy and to learn more about products and services from Bloomberg.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Join Bloomberg Intelligence pharma and biotech analysts Michael Shah and John Murphy as they examine the latest developments in obesity following the European Association for the Study of Diabetes (EASD) Conference. Gain insight into the current market landscape and emerging innovations on the horizon in the weight-loss market.

Access a broad range of analysis, research, insight and actionable ideas with Bloomberg webinars.